Long intergenic non-protein coding RNA 904 (LINC00904)

Long intergenic non-protein coding RNA 904 (LINC00904) is a non-coding RNA gene that produces a transcript longer than 200 nucleotides and does not overlap with protein-coding genes[1][5]. As a lincRNA, its function may involve gene regulation, chromatin remodeling, or RNA stabilization, but there are currently no experimentally validated biological functions, disease associations, or roles as a therapeutic target reported in the current scientific and clinical literature[1][5]. No drugs, biomarkers, or clinical uses are associated with LINC00904. LINC00904 is a well-annotated lincRNA, but there are no published data associating it with any disease, drug, or therapeutic mechanism[1]. It is not considered a drug target, receptor, enzyme, transporter, or classical therapeutic target. The gene has multiple aliases, but no evidence suggests confusion with other similarly named lincRNAs. If the intent is to catalog clinical targets, LINC00904 would be classified as a long intergenic non-coding RNA without current therapeutic relevance. If you were seeking information on a similar but *different* lincRNA (for example, LINC00504 or LINC00324, which are associated with cancer), these are distinct entities and not aliases for LINC00904[2][3]. In summary, LINC00904 is a valid lincRNA gene, but *not* a therapeutic target. There is no function, disease role, or therapy described for LINC00904 in scientific databases or high-quality reviews. The entry is correct in naming and identification, but incorrect *as a drug target*.

Other names

CTC-523E23.13CTC-523E23.14CTC-523E23.15LINC00904